Hirslanden

The Hirslanden Group operates the largest private hospital network in Switzerland with over two decades of experience. It delivers high-quality inpatient and outpatient care across multiple specialties using advanced technology. The group has an excellent reputation for complex procedures in cardiology, oncology, neurology/neurosurgery, orthopaedics, reproductive medicine/IVF and more. It serves both Swiss residents and international patients with personalized care models.

Ranked #65 globally by Newsweek among clinics in 2025.

Satisfaction rate reported at ~88% from over 110,000 patients treated annually.

No clinical trial pipeline as it does not develop drugs or devices.

Offers innovative treatments such as radiotherapy for cancer and stem cell therapy within its service portfolio.

Provides digital health solutions via the Compassana health platform.

Employs over 8,000 staff including more than 3,000 doctors across its hospitals.

Operates specialized centers for preventive medicine/diagnostics for international patients at locations like Klinik Im Park in Zurich.

Part of Mediclinic International since acquisition.